TRACKER Debuts at Conference with Poster Presentation

---

At the Olivia Newton-John Cancer Research Institute (ONJCRI) 10-Year Anniversary Conference, TRACKER reached a major milestone with its first poster presentation, showcasing important insights from its work.

---

Lung cancer remains Australia’s leading cause of cancer-related deaths, but the TRACKER Biobank is bringing hope and innovation to the problem. At the Olivia Newton-John Cancer Research Institute (ONJCRI) 10-Year Anniversary Conference, TRACKER reached a major milestone with its first poster presentation, showcasing important insights from its work to date.  

The presentation, delivered by Dr. Sarah Yeo, a talented clinician and PhD student, shared early findings from the initial 70 patients recruited to TRACKER — Australia’s first national lung cancer biobank. These findings emphasise the biobank’s role in accelerating critical lung cancer research and shaping future breakthroughs.  

"TRACKER is more than a biobank. It’s a catalyst for change, providing researchers with the resources they need to tackle the most pressing challenges in lung cancer treatment.”

_____________

Dr. Sarah Yeo, TRACKER PhD Student 

What's Next?

This debut marks the start of an exciting journey for TRACKER. With its sights set on expanding recruitment and furthering research, TRACKER is committed to making a meaningful impact in lung cancer outcomes.  

“We envision a future where lung cancer is no longer the leading cause of cancer-related deaths, thanks to collaborative efforts and innovative science,” Dr. Yeo added.